March 27, 2017 3:27 AM ET


Company Overview of Taisho Pharmaceutical Co., Ltd.

Company Overview

Taisho Pharmaceutical Co., Ltd. manufactures and sells over-the-counter (OTC) medicines and health-related products. It offers products in the areas of central nervous system (CNS), diabetes, immunology/allergy, and infectious diseases; and self-medication products, such as Rx-to-OTC switch drugs, eye drops, constipation suppositories, cold remedies, and hair re-growth treatment medication products; prescription pharmaceutical products for infectious diseases, orthopedic disorders, CNS diseases, and metabolic diseases. The company, through its subsidiaries in Japan and internationally, engages in the research, development, manufacture, and sale of pharmaceuticals and health-related products;...

3-24-1, Takada


Tokyo,  170-8633


Founded in 2011


81 3 3985 1111


81 3 3985 8627

Key Executives for Taisho Pharmaceutical Co., Ltd.

President and Representative Director
Executive Vice President and Director
Executive Director
Senior Executive Officer and Director
Corporate Adviser and Director
Age: 79
Compensation as of Fiscal Year 2016.

Taisho Pharmaceutical Co., Ltd. Key Developments

Taisho Pharmaceutical Co., Ltd. and Bayer Yakuhin, Ltd. Sign Licensing and Commercialization Agreement

Taisho Pharmaceutical Holdings Co., Ltd. has announced that Taisho Pharmaceutical Co., Ltd. and Bayer Yakuhin, Ltd. signed an agreement on July 11, 2016 regarding OTC drug products in Japan for the allergy treatment Claritin (Licensing and Commercialization Agreement).

Taisho Pharmaceutical Co., Ltd. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016

Taisho Pharmaceutical Co., Ltd. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016 . Venue: Grand Hyatt, Tokyo, Japan.

Polyphor and Taisho Pharmaceutical Enter into Research Collaboration on Novel Drug Candidates

Polyphor Ltd. announced the signing of a research collaboration agreement with Taisho Pharmaceutical Co., Ltd. The parties will collaborate on the identification of novel drug candidates based on Polyphor's proprietary macrocycle platform.

Similar Private Companies By Industry

Company Name Region
ABsize Inc. Asia
AccuRna, Inc. Asia
ACE Japan, L.L.C. Asia
Advanced Immunotherapy Co., Ltd. Asia
AETAS Pharma Co.,Ltd. Asia

Recent Private Companies Transactions

December 26, 2016
Dr. Program Co., Ltd.
July 4, 2016
DHG Pharmaceutical Joint Stock Company

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Taisho Pharmaceutical Co., Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at